Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Karima Rjiba-Touati"'
Publikováno v:
Biomarkers. 27:659-670
Bromuconazole, a fungicide belonging to the triazole family, is a plant protection product used to control, repel or destroy fungi that may develop on crops. We investigated the pro-apoptotic effect of bromuconazole and the role of oxidative stress i
Publikováno v:
Biomarkers. 27:599-607
Autor:
Hiba, Hamdi, Karima, Rjiba-Touati, Imen, Ayed-Boussema, Assma, M'nassri, Hanen, Chaabani, Siwar, Rich, Salwa, Abid-Essefi
Publikováno v:
NeuroToxicology. 89:184-190
Epoxiconazole is among the most widely applied pesticides worldwide. The increased use of these products could cause toxic effects on human health which are mainly associated with its residues in food or occupational exposure in agriculture. The brai
Publikováno v:
Toxicology in Vitro. 89:105587
Publikováno v:
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 27(6)
Bromuconazole is a widely used triazole against various fungi disease. It's employment provokes harmful effects on the environment and human health. In the present study, we explored bromuconazole toxic effects in both rat brain tissue and SH-SY5Y ce
Publikováno v:
Environmental science and pollution research internationalReferences. 29(10)
Bromuconazole is a triazole pesticide used to protect vegetables and fruits against diverse fungi pathologies. However, its utilization may be accompanied by diverse tissue injuries. In this study, we evaluated the biochemical and histopathological m
Autor:
A Azzebi, Ines Amara, Salwa Abid, I Ben Salem, Yosra Guedri, Abdellatif Achour, Hassen Bacha, Karima Rjiba-Touati, M Bousabbeh
Publikováno v:
Human & Experimental Toxicology. 37:848-858
Etoposide (ETO) and methotrexate (MTX) are two effective chemotherapeutic drugs. However, the clinical use of these drugs is limited by its toxicity in normal tissues, especially in kidney and in liver tissues. Recombinant human erythropoietin (rhEPO
Autor:
Karima Rjiba-Touati, Nidhal Soualeh, Imen Ayed-Boussema, Salwa Abid, Hassen Bacha, Abdellatif Achour
Publikováno v:
Experimental Biology and Medicine. 238:943-950
Cisplatin (CDDP) and mitomycin C (MMC), two alkylating agents used against various solid tumours, are a common source of acute kidney injury. Thus, strategies for minimizing CDDP and MMC toxicity are of a clinical interest. In this study, we aimed to
Autor:
Karima Rjiba-Touati, Salwa Abid, Hassen Bacha, Yosra Guedri, Imen Ayed-Boussema, Abdelatif Achour
Publikováno v:
Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 753:48-53
Mitomycin C (MMC) is one of the most effective chemotherapeutic agents. However, during clinical use several side effects may occur. Recombinant human erythropoietin (rhEPO), a glycoprotein that regulates haematopoiesis, has been shown to exert an im
Publikováno v:
International Journal of Toxicology. 30:510-517
Cisplatin (Cisp) is one of the most widely used chemotherapeutic agents for the treatment of several human malignancies. The efficacy of Cisp is dose dependent and at higher doses serious kidney injury may occur. Recombinant human erythropoietin (rhE